Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.5144/0256-4947.1992.328 | DOI Listing |
Cochrane Database Syst Rev
June 2024
Department of Comparative Biology and Experimental Medicine, University of Calgary, Calgary, Canada.
PLoS One
May 2024
Department of Pharmacology, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Ital J Pediatr
November 2023
Department of Medicine, Surgery, and Health Sciences, University of Trieste, Trieste, Italy.
Background: Erythropoietic protoporphyria is a rare disorder which represents an important health problem in children, causing painful photosensitivity. Little is known on the correlation between genetic profile and clinical manifestations. The standard of care for Erythropoietic protoporphyria is based on avoiding sun and using sun protections, but recent literature has suggested that cimetidine may have a role in improving sun sensitivity.
View Article and Find Full Text PDFJ Pharm Sci
January 2024
Quantitative Pharmacology and Pharmacometrics (QP2), Merck & Co., Inc, Rahway, NJ, USA. Electronic address:
Cisplatin is widely used for the treatment of various types of cancer. However, cisplatin-induced nephrotoxicity (CIN) is frequently observed in patients receiving cisplatin therapy which poses a challenge in its clinical utility. Currently used clinical biomarkers for CIN are not adequate for early detection of nephrotoxicity, hence there is a need to identify potential early biomarkers in predicting CIN.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!